Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics
Open Access
- 8 December 2022
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 209, 105484
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
- Genome British Columbia
- Mitacs
This publication has 73 references indexed in Scilit:
- Sesterterpenoids Isolated from a Northeastern Pacific Phorbas sp.The Journal of Organic Chemistry, 2013
- Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymesBiochemical Journal, 2013
- Human Subtilase SKI-1/S1P Is a Master Regulator of the HCV Lifecycle and a Potential Host Cell Target for Developing Indirect-Acting Antiviral AgentsPLOS Pathogens, 2012
- Bafilomycins Produced in Culture by Streptomyces spp. Isolated from Marine Habitats Are Potent Inhibitors of AutophagyJournal of Natural Products, 2009
- Bryostatin-1: Pharmacology and Therapeutic Potential as a CNS DrugCNS Drug Reviews, 2006
- PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKCBlood, 2005
- Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication ComplexesJournal of Virology, 2004
- Characterization of the Interaction of Ingenol 3-Angelate with Protein Kinase CCancer Research, 2004
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymesFEBS Letters, 1996